Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chun-Jen Liu

Showing results (211-220 of 400) with videos related to

Pageof 40
Sort By:
International Journal of Epidemiology|November 19, 2002
Increased risk for hepatitis B-related liver cirrhosis in relatives of patients with hepatocellular carcinoma in northern TaiwanMing-Whei Yu, Hung-Chuen Chang, Pei-Jer Chen, et al.
Gastroenterology|March 15, 2005
RNA interference-mediated control of hepatitis B virus and emergence of resistant mutantHui-Lin Wu, Li-Rung Huang, Chuan-Chuan Huang, et al.
International Journal of Epidemiology|September 21, 2005
Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinomaChun-Chieh Chen, Shi-Yi Yang, Chun-Jen Liu, et al.
The Journal of Infectious Diseases|November 13, 2014
Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapyCheng-Chao Liang, Chen-Hua Liu, Chen-Shuan Chung, et al.
Journal of Viral Hepatitis|January 26, 2020
Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairmentChen-Hua Liu, Sheng-Shun Yang, Cheng-Yuan Peng, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|June 6, 2020
Elbasvir/grazoprevir is effective and tolerable for the treatment of HCV GT1-infected patients: A real world multicenter observatory study in TaiwanPin-Nan Cheng, Chi-Yi Chen, Ming-Lung Yu, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|August 17, 2024
Higher hepatitis B core-specific T cell response is associated with a lower risk of clinical relapse after discontinuation of oral antiviral treatmentTai-Chung Tseng, Huei-Ru Cheng, Tung-Hung Su, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 19, 2024
Trajectories of hepatic steatosis and incidence of cardiovascular disease over a 29-year follow-upMing-Whei Yu, Wan-Jung Wu, Chih-Lin Lin, et al.
Antiviral Therapy|April 14, 2010
Differential effects of interferon and lamivudine on serum HBV RNA inhibition in patients with chronic hepatitis BYi-Wen Huang, Kazuaki Chayama, Masataka Tsuge, et al.
Journal of Hepatology|October 7, 2004
Quantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysisShiou-Hwei Yeh, Ching-Yi Tsai, Jia-Horng Kao, et al.
Pageof 40

Showing results (211-220 of 400) with videos related to

Sort By:
Pageof 40
International Journal of Epidemiology|November 19, 2002
Increased risk for hepatitis B-related liver cirrhosis in relatives of patients with hepatocellular carcinoma in northern TaiwanMing-Whei Yu, Hung-Chuen Chang, Pei-Jer Chen, et al.
Gastroenterology|March 15, 2005
RNA interference-mediated control of hepatitis B virus and emergence of resistant mutantHui-Lin Wu, Li-Rung Huang, Chuan-Chuan Huang, et al.
International Journal of Epidemiology|September 21, 2005
Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinomaChun-Chieh Chen, Shi-Yi Yang, Chun-Jen Liu, et al.
The Journal of Infectious Diseases|November 13, 2014
Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapyCheng-Chao Liang, Chen-Hua Liu, Chen-Shuan Chung, et al.
Journal of Viral Hepatitis|January 26, 2020
Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairmentChen-Hua Liu, Sheng-Shun Yang, Cheng-Yuan Peng, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|June 6, 2020
Elbasvir/grazoprevir is effective and tolerable for the treatment of HCV GT1-infected patients: A real world multicenter observatory study in TaiwanPin-Nan Cheng, Chi-Yi Chen, Ming-Lung Yu, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|August 17, 2024
Higher hepatitis B core-specific T cell response is associated with a lower risk of clinical relapse after discontinuation of oral antiviral treatmentTai-Chung Tseng, Huei-Ru Cheng, Tung-Hung Su, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 19, 2024
Trajectories of hepatic steatosis and incidence of cardiovascular disease over a 29-year follow-upMing-Whei Yu, Wan-Jung Wu, Chih-Lin Lin, et al.
Antiviral Therapy|April 14, 2010
Differential effects of interferon and lamivudine on serum HBV RNA inhibition in patients with chronic hepatitis BYi-Wen Huang, Kazuaki Chayama, Masataka Tsuge, et al.
Journal of Hepatology|October 7, 2004
Quantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysisShiou-Hwei Yeh, Ching-Yi Tsai, Jia-Horng Kao, et al.
Pageof 40